TABLE 3.
Ten-Year Follow-up on HRQoL, by Treatment Groups
| Endovascular coiling (n = 809) | Neurosurgery clipping (n = 835) | T-test | |||
|---|---|---|---|---|---|
| No. | EQ-5D-3L utility* Mean (SD) | No. | EQ-5D-3L utility* Mean (SD) | (P value) | |
| 2 mo | 718 | 0.64 (0.34) | 716 | 0.59 (0.36) | 2.95 (.003) |
| Year 1 | 772 | 0.68 (0.34) | 772 | 0.63 (0.36) | 2.77 (.006) |
| Year 2 | 728 | 0.69 (0.35) | 722 | 0.64 (0.36) | 2.56 (.011) |
| Year 3 | 708 | 0.69 (0.35) | 701 | 0.65 (0.36) | 2.00 (.045) |
| Year 4 | 704 | 0.68 (0.36) | 697 | 0.65 (0.37) | 1.58 (.113) |
| Year 5 | 692 | 0.68 (0.36) | 689 | 0.64 (0.38) | 1.91 (.056) |
| Year 6 | 660 | 0.69 (0.37) | 667 | 0.63 (0.38) | 2.78 (.005) |
| Year 7 | 679 | 0.67 (0.38) | 655 | 0.61 (0.40) | 3.15 (.002) |
| Year 8 | 667 | 0.67 (0.38) | 677 | 0.60 (0.40) | 2.98 (.003) |
| Year 9 | 652 | 0.65 (0.39) | 646 | 0.60 (0.40) | 2.12 (.034) |
| Year 10 | 653 | 0.64 (0.39) | 640 | 0.59 (0.41) | 2.19 (.029) |
*Deaths were included as utility equals to zero.